CMO of Wolters Kluwer: GenAI helps with drug diversion
As he describes what ' s in store for the company in 2024, Dr. Peter Bonis discusses its recent survey on consumer concerns around artificial intelligence and its acquisition of Invistics.
Source: Healthcare ITNews Videos - Category: Information Technology Source Type: video
More News: Information Technology | Mergers and Aquisitions